ClassID:

117029

C12Y304/24011 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Metalloendopeptidases (3.4.24) Neprilysin (3.4.24.11), i.e. enkephalinase or neutral endopeptidase 24.11

Recent Application in this class:
#1
20250236818
2025-07-24

HAIR REMOVAL BY MEANS OF DETERGENT/DETERGENT ADDITIVES CONTAINING ENZYMES

#2
20240271092
2024-08-15

Methods of Treating Cancer and Infectious Diseases Using Cell Based Therapies

#3
20230233615
2023-07-27

PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE

#4
20210395716
2021-12-23

METHODS AND COMPOSITIONS FOR TREATMENT OF PROTEIN AGGREGATION-BASED DISORDERS

#5
20210261936
2021-08-26

COMPOSITIONS AND METHODS FOR ENHANCING THE UBIQUITIN PROTEASOME SYSTEM

#6
20200390857
2020-12-17

METHOD FOR INCREASING NEPRILYSIN EXPRESSION AND ACTIVITY

#7
20190282662
2019-09-19

METHOD FOR INCREASING NEPRILYSIN EXPRESSION AND ACTIVITY

#8
20190144825
2019-05-16

Methods of treating cancer using cell based therapies

#9
20190119323
2019-04-25

Bone delivery conjugates and method of using same to target proteins to bone

#10
20150140028
2015-05-21

Recombinant bacterium and uses thereof

#11
20140377319
2014-12-25

ALTERING PROTEIN CONCENTRATIONS IN CEREBROSPINAL FLUID AND/OR BRAIN INTERSTITIAL FLUID

#12
20140341882
2014-11-20

PHARMACEUTICAL PRODUCT FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE

#13
20120237496
2012-09-20

PROTEASE VARIANTS

#14
20110319480
2011-12-29

Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens

#15
20110033463
2011-02-10

APHERESIS, ADMINISTRATION OF AGENT, OR COMBINATION THEREOF

#16
20110027251
2011-02-03

NOVEL USES FOR 4-PHENYLBUTYRATE (4PBA) AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS

#17
20100260807
2010-10-14

Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens

#18
20100240125
2010-09-23

Bone delivery conjugates and method of using same to target proteins to bone

#19
20100221234
2010-09-02

Bone delivery conjugates and method of using same to target proteins to bone

#20
20080317732
2008-12-25

Amyloid peptide inactivating enzyme to treat alzheimer's disease peripherally

#21
20080274096
2008-11-06

Fusion Proteins Having a Modulated Half-Life in Plasma

#22
20080234214
2008-09-25

Oligonucleotide-containing pharmacological compositions and their use

#23
20080167257
2008-07-10

Oligonucleotide-containing pharmacological compositions and their use

#24
20080161257
2008-07-03

Oligonucleotide-containing pharmacological compositions and their use

#25
20060171926
2006-08-03

Gene therapy for neurometabolic disorders

#26
20060029590
2006-02-09

Administration of neutral endopeptidase to treat inflammatory bowel disease

#27
20060014687
2006-01-19

Bone delivery conjugates and method of using same to target proteins to bone

#28
20050069569
2005-03-31

Method and compositions for promoting osteogenesis

#29
20050059056
2005-03-17

Antigenic gp100 (154-162) compounds for therapy and diagnosis and methods for using same